Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Astellas Pharma Inc.

    OTC: ALPMF · Real-Time Price · USD
    10.10
    0.00 (0.00%)
    At close: Jun 03, 2025, 3:54 PM

    Astellas Pharma Statistics

    Share Statistics

    Astellas Pharma has 1.79B shares outstanding. The number of shares has increased by -0.17% in one year.

    Shares Outstanding

    n/a
    		 1.79B

    Shares Change (YoY)

    n/a
    		 -0.17%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 1.71B

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 3.39M, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.39M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 999.99

    Valuation Ratios

    The PE ratio is 178.21 and the forward PE ratio is 0.11. Astellas Pharma's PEG ratio is -2.16.

    PE Ratio

    n/a
    		 178.21

    Forward PE

    n/a
    		 0.11

    PS Ratio

    n/a
    		 1.89

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 1.9

    P/FCF Ratio

    n/a
    		 33.76

    PEG Ratio

    n/a
    		 -2.16
    Financial Ratio History

    Enterprise Valuation

    Astellas Pharma has an Enterprise Value (EV) of 3,707.6B.

    EV / Sales

    n/a
    		 2.31

    EV / EBITDA

    n/a
    		 19.03

    EV / EBIT

    n/a
    		 21.5

    EV / FCF

    n/a
    		 41.21

    Financial Position

    The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.63.

    Current Ratio

    n/a
    		 0.93

    Quick Ratio

    n/a
    		 0.74

    Debt / Equity

    n/a
    		 0.63

    Debt / EBITDA

    n/a
    		 5.16

    Debt / FCF

    n/a
    		 11.18

    Interest Coverage

    n/a
    		 2.13

    Financial Efficiency

    Return on Equity is 1.07% and Return on Invested Capital is 0.63%.

    Return on Equity

    n/a
    		 1.07%

    Return on Assets

    n/a
    		 0.48%

    Return on Invested Capital

    n/a
    		 0.63%

    Revenue Per Employee

    n/a
    		 $108,694,049.07

    Profits Per Employee

    n/a
    		 $1,155,279.92

    Employee Count

    n/a
    		 14,754

    Asset Turnover

    n/a
    		 0.45

    Inventory Turnover

    n/a
    		 1.18

    Taxes

    Income Tax

    n/a
    		 7.92B

    Effective Tax Rate

    n/a
    		 31.74%

    Stock Price Statistics

    The stock price has increased by 5.65% in the last 52 weeks. The beta is 0.13, so Astellas Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.13

    52-Week Price Change

    n/a
    		 5.65%

    50-Day Moving Average

    n/a
    		 9.59

    200-Day Moving Average

    n/a
    		 10.35

    Relative Strength Index (RSI)

    n/a
    		 62.42

    Average Volume (20 Days)

    n/a
    		 1,774

    Income Statement

    In the last 12 months, Astellas Pharma had revenue of 1,603.7B and earned 17.05B in profits. Earnings per share was 9.5.

    Revenue

    n/a
    		 1,603.7B

    Gross Profit

    n/a
    		 1,311.2B

    Operating Income

    n/a
    		 25.52B

    Net Income

    n/a
    		 17.05B

    EBITDA

    n/a
    		 194.81B

    EBIT

    n/a
    		 36.97B

    Earnings Per Share (EPS)

    n/a
    		 9.5
    Full Income Statement

    Balance Sheet

    The company has 335.69B in cash and 1,005.7B in debt, giving a net cash position of -670.03B.

    Cash & Cash Equivalents

    n/a
    		 335.69B

    Total Debt

    n/a
    		 1,005.7B

    Net Cash

    n/a
    		 -670.03B

    Retained Earnings

    n/a
    		 809.4B

    Total Assets

    n/a
    		 3,735.5B

    Working Capital

    n/a
    		 -133.15B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 172.47B and capital expenditures -82.5B, giving a free cash flow of 89.98B.

    Operating Cash Flow

    n/a
    		 172.47B

    Capital Expenditures

    n/a
    		 -82.5B

    Free Cash Flow

    n/a
    		 89.98B

    FCF Per Share

    n/a
    		 50.18
    Full Cash Flow Statement

    Margins

    Gross margin is 81.76%, with operating and profit margins of 1.59% and 1.06%.

    Gross Margin

    n/a
    		 81.76%

    Operating Margin

    n/a
    		 1.59%

    Pretax Margin

    n/a
    		 1.56%

    Profit Margin

    n/a
    		 1.06%

    EBITDA Margin

    n/a
    		 12.15%

    EBIT Margin

    n/a
    		 1.59%

    FCF Margin

    n/a
    		 5.61%

    Dividends & Yields

    ALPMF pays an annual dividend of $0.73, which amounts to a dividend yield of 5.03%.

    Dividend Per Share

    n/a
    		 $0.73

    Dividend Yield

    n/a
    		 5.03%

    Dividend Growth (YoY)

    n/a
    		 6.8%

    Payout Ratio

    n/a
    		 366.97%

    Earnings Yield

    n/a
    		 0.56%

    FCF Yield

    n/a
    		 2.96%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ALPMF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $47.5

    Lynch Upside

    n/a
    		 370.3%

    Graham Number

    n/a
    		 436.27

    Graham Upside

    n/a
    		 4219.5%

    Stock Splits

    The last stock split was on Mar 27, 2014. It was a forward split with a ratio of 5:1.

    Last Split Date

    n/a
    		 Mar 27, 2014

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 5:1

    Scores

    Altman Z-Score

    n/a
    		 0.81

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist